G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Tolerance to opioids frequently follows repeated drug administration and affects the clinical utility of these analgesics. Studies in simple cellular systems have demonstrated that prolonged activation of opioid receptors produces homologous receptor desensitization by G‐protein receptor kinase mediated receptor phosphorylation and subsequent β ‐arrestin binding. To define the role of this regulatory mechanism in the control of the electrophysiological and behavioral responses to opioids, we used mice having a targeted disruption of the G‐protein receptor kinase 3 (GRK3) gene. Mice lacking GRK3 did not differ from wild‐type littermates neither in their response latencies to noxious stimuli on the hot‐plate test nor in their acute antinociceptive responses to fentanyl or morphine. Tolerance to the electrophysiological response to the opioid fentanyl, measured in vitro in the hippocampus, was blocked by GRK3 deletion. In addition, tolerance to the antinociceptive effects of fentanyl was significantly reduced in GRK3 knockouts compared to wild‐type littermate controls. Tolerance to the antinociceptive effects of morphine was not affected by GRK3 deletion although morphine tolerance in hippocampal slices from GRK3 knockout mice was significantly inhibited. Tolerance developed more slowly in vitro to morphine than fentanyl supporting previous work in in vitro systems showing a correlation between agonist efficacy and GRK3‐mediated desensitization. The results of these studies suggest that GRK3‐mediated mechanisms are important components of both electrophysiologic and behavioral opioid tolerance. Fentanyl, a high efficacy opioid, more effectively produced GRK3‐dependent effects than morphine, a low efficacy agonist. British Journal of Pharmacology (2004) 141 , 55–64. doi: 10.1038/sj.bjp.0705595
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640 · cited 1×
“NMDA antagonists, known to inhibit learning in a variety of models (Morris et al., 1986), have also been reported to also inhibit opioid tolerance by several groups (e.g., Trujillo & Akil, 1991).”
BackgroundHeritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00197-3 · Cited by 656
Cited by
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L. M., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 860
Self-citationRegulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance
Williams, J. T., Ingram, S. L., Henderson, G., Chavkin, C., von Zastrow, M., Schulz, S., Koch, T., Evans, C. J., & Christie, M. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005942 · Cited by 802
Self-citationPhysiological Roles of G Protein–Coupled Receptor Kinases and Arrestins
Premont, R. T., & Gainetdinov, R. R. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154731 · Cited by 494
G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
Gurevich, E. V., Tesmer, J. J. G., Mushegian, A., & Gurevich, V. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.08.001 · Cited by 423
Agonist‐selective mechanisms of GPCR desensitization
Kelly, E., Bailey, C. P., & Henderson, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707604 · Cited by 388
Metadata
- Authors
- Terman, G. W., Jin, W., Cheong, Y., Lowe, J., Caron, M. G., Lefkowitz, R. J., & Chavkin, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2004-01
- Volume
- 141
- Issue
- 1
- Pages
- 55-64
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2032568216
- Cited by
- 96
- References
- 2
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.